United Healthcare Expands Access to Straticyte™ Test for Oral Cancer Risk Assessment

Proteocyte has announced that United Healthcare will now cover the Straticyte™ test—a predictive diagnostic tool for assessing the risk of oral cancer—in its commercial, Medicare Advantage, and Managed Medicaid plans. This breakthrough coverage allows more patients with oral potentially malignant disorders (OPMD) to access an advanced risk assessment without additional biopsies, potentially improving early intervention and outcomes.

Read More